| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/GUT.2008.176271 |
| P698 | PubMed publication ID | 20442200 |
| P2093 | author name string | Yang Xu | |
| Bin Yu | |||
| Jian Zhou | |||
| Bin Wu | |||
| Jia Fan | |||
| Yuan Ji | |||
| Shuang-Jian Qiu | |||
| Wei-Zhong Wu | |||
| Guo-Ming Shi | |||
| Xin-Rong Yang | |||
| Ying-Hong Shi | |||
| Bo-Heng Zhang | |||
| Guo-Huan Yang | |||
| P433 | issue | 7 | |
| P921 | main subject | tumor angiogenesis | Q110495869 |
| angiogenesis | Q539568 | ||
| biomarker | Q864574 | ||
| hepatocellular carcinoma | Q1148337 | ||
| P304 | page(s) | 953-962 | |
| P577 | publication date | 2010-05-04 | |
| P1433 | published in | Gut | Q5621669 |
| P1476 | title | High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma | |
| P478 | volume | 59 |
| Q34084021 | A molecular prognostic model predicts esophageal squamous cell carcinoma prognosis |
| Q36089938 | A morpho-molecular prognostic model for hepatocellular carcinoma |
| Q37632145 | A nomogram predicting pulmonary metastasis of hepatocellular carcinoma following partial hepatectomy |
| Q38852804 | A pivotal role of Krüppel-like factor 5 in regulation of cancer stem-like cells in hepatocellular carcinoma. |
| Q35741706 | A three-protein signature and clinical outcome in esophageal squamous cell carcinoma |
| Q37681702 | Alpha-1-fucosidase as a prognostic indicator for hepatocellular carcinoma following hepatectomy: a large-scale, long-term study |
| Q36083213 | Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection. |
| Q100945779 | BCL11B suppresses tumor progression and stem cell traits in hepatocellular carcinoma by restoring p53 signaling activity |
| Q38078237 | Biomarkers for predicting future metastasis of human gastrointestinal tumors. |
| Q39459026 | CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling |
| Q55477963 | CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial. |
| Q35782494 | CD44 expression in patients with combined hepatocellular cholangiocarcinoma |
| Q83968175 | CEACAM1 cytoplastic expression is closely related to tumor angiogenesis and poorer relapse-free survival after curative resection of hepatocellular carcinoma |
| Q35957183 | CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection |
| Q39197682 | Cancer Stem Cells and Their Microenvironment: Biology and Therapeutic Implications. |
| Q90638405 | Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy |
| Q33778124 | Cancer stem cells and tumor metastasis (Review). |
| Q34975197 | Cancer stem cells in primary liver cancers: pathological concepts and imaging findings. |
| Q36793453 | Cancer stem cells in the development of liver cancer |
| Q33688897 | Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN. |
| Q52620499 | Cellular prognostic markers in hepatitis-related hepatocellular carcinoma. |
| Q44421418 | Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection |
| Q100395396 | Clinical development of CAR T cell therapy in China: 2020 update |
| Q34357073 | Clinical implications of cancer stem cell biology in hepatocellular carcinoma |
| Q55227617 | Clinical outcome of hepatocellular carcinoma can be predicted by the expression of hepatic progenitor cell markers and serum tumour markers. |
| Q53526112 | Clinicopathological significance and prognostic value of the expression of the cancer stem cell marker CD133 in hepatocellular carcinoma: a meta-analysis. |
| Q64280134 | Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma |
| Q34776673 | Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization: a propensity score analysis. |
| Q36478152 | Corona Enhancement and Mosaic Architecture for Prognosis and Selection Between of Liver Resection Versus Transcatheter Arterial Chemoembolization in Single Hepatocellular Carcinomas >5 cm Without Extrahepatic Metastases: An Imaging-Based Retrospecti |
| Q38822287 | Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines. |
| Q38673577 | Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis |
| Q28242740 | DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival |
| Q35855687 | Developmental Stage-Specific Hepatocytes Induce Maturation of HepG2 Cells by Rebuilding the Regulatory Circuit |
| Q35987882 | Divergent roles of CD44 and carcinoembryonic antigen in colon cancer metastasis |
| Q50042111 | Dynamic network biomarker indicates pulmonary metastasis at the tipping point of hepatocellular carcinoma |
| Q26783895 | Evaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imaging |
| Q36110393 | Expression of K19 and K7 in dysplastic nodules and hepatocellular carcinoma |
| Q28390991 | Forfeited hepatogenesis program and increased embryonic stem cell traits in young hepatocellular carcinoma (HCC) comparing to elderly HCC |
| Q28077270 | Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer |
| Q88109421 | HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis |
| Q38814227 | HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma |
| Q38155513 | Hepatic progenitor cells: their role and functional significance in the new classification of primary liver cancers. |
| Q37099380 | Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma |
| Q36835856 | High expression of cancer stem cell markers in cholangiolocellular carcinoma |
| Q82299264 | Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis |
| Q38947665 | Identification of New Players in Hepatocarcinogenesis: Limits and Opportunities of Using Tissue Microarray (TMA). |
| Q36526219 | Immunohistochemical Expression and Clinical Significance of Suggested Stem Cell Markers in Hepatocellular Carcinoma |
| Q39253341 | Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies |
| Q90291739 | Inflammation-nutrition score predicts prognosis of patients with resectable hepatocellular carcinoma |
| Q88636914 | Insufficient radiofrequency ablation promotes hepatocellular carcinoma cell progression via autophagy and the CD133 feedback loop |
| Q64996870 | Interpretation of interlocking key issues of cancer stem cells in malignant solid tumors. |
| Q53274537 | Leukocyte telomere length predicts overall survival in hepatocellular carcinoma treated with transarterial chemoembolization. |
| Q35585395 | Long noncoding RNA MALAT-1 enhances stem cell-like phenotypes in pancreatic cancer cells |
| Q36216692 | M2-polarized macrophages in keratocystic odontogenic tumor: relation to tumor angiogenesis |
| Q26853543 | Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival |
| Q57174410 | Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour |
| Q36788544 | Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis. |
| Q89599652 | MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming |
| Q35048768 | Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? |
| Q64943233 | Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus. |
| Q87676067 | Nestin involvement in tissue injury and cancer--a potential tumor marker? |
| Q37093999 | Nestin overexpression in hepatocellular carcinoma associates with epithelial-mesenchymal transition and chemoresistance |
| Q26824035 | Nestin: a novel angiogenesis marker and possible target for tumor angiogenesis |
| Q35551840 | Notch3 functions as a regulator of cell self-renewal by interacting with the β-catenin pathway in hepatocellular carcinoma |
| Q35999457 | Overexpression Of Hepatocyte Nuclear Factor-1beta Predicting Poor Prognosis Is Associated With Biliary Phenotype In Patients With Hepatocellular Carcinoma |
| Q90486716 | Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer |
| Q90441634 | Overexpression of epithelial cell adhesion molecule as a predictor of poor outcome in patients with hepatocellular carcinoma |
| Q37377999 | Overexpression of microRNA-21 strengthens stem cell-like characteristics in a hepatocellular carcinoma cell line |
| Q57782479 | Pathologie hépatique Cirrhose et carcinome hépatocellulaire : indications et rôles de la biopsie hépatique |
| Q37564510 | Peritumoral ductular reaction: a poor postoperative prognostic factor for hepatocellular carcinoma |
| Q37220518 | Persistent effect of mTOR inhibition on preneoplastic foci progression and gene expression in a rat model of hepatocellular carcinoma. |
| Q37725279 | Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection |
| Q38280688 | Prognostic significance of TP53 expression for patients with hepatocellular carcinoma: a meta-analysis |
| Q37584674 | Prognostic significance of vascular endothelial growth factor expression in hepatocellular carcinoma tissue: a meta-analysis |
| Q37354173 | Prognostic value of fever grade combined with neutrophil percentage in hepatocellular carcinoma patients presenting fever as the initial manifestation |
| Q37565162 | Prognostic value of the expression of cancer stem cell-related markers CD133 and CD44 in hepatocellular carcinoma: From patients to patient-derived tumor xenograft models |
| Q34143795 | Proliferative ductular reactions correlate with hepatic progenitor cell and predict recurrence in HCC patients after curative resection |
| Q42330057 | Proteomics approaches for early detection and targeted therapy of hepatocellular carcinoma |
| Q57069778 | Reactive Ductules Are Associated With Angiogenesis and Tumor Cell Proliferation in Pediatric Liver Cancer |
| Q58609658 | Recent progress in the emerging role of exosome in hepatocellular carcinoma |
| Q43506762 | Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice. |
| Q41773876 | Regulatory role of miR-142-3p on the functional hepatic cancer stem cell marker CD133. |
| Q28279753 | Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers |
| Q37706763 | Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications |
| Q35063797 | Silencing of DLGAP5 by siRNA significantly inhibits the proliferation and invasion of hepatocellular carcinoma cells |
| Q35631841 | Stem cells in liver diseases and cancer: recent advances on the path to new therapies |
| Q44536329 | Sublethal heat treatment promotes epithelial-mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma |
| Q46151710 | TP53 immunohistochemical expression is associated with the poor outcome for hepatocellular carcinoma: evidence from a meta-analysis |
| Q37584718 | TP53 mutation is associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a meta-analysis |
| Q94545537 | Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells |
| Q37153412 | Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study |
| Q34708309 | The 3' UTR variants in the GRP78 are not associated with overall survival in resectable hepatocellular carcinoma. |
| Q40154855 | The C-terminus domain of the hepatitis B virus x protein stimulates the proliferation of mouse foetal hepatic progenitor cells, although it is not required for the formation of spheroids |
| Q33985495 | The IL-8/CXCR1 axis is associated with cancer stem cell-like properties and correlates with clinical prognosis in human pancreatic cancer cases |
| Q42743859 | The growth pattern of transplanted normal and nodular hepatocytes. |
| Q36730484 | The inhibitory effect of rapamycin on the oval cell response and development of preneoplastic foci in the rat. |
| Q35609756 | The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer |
| Q64110601 | Therapeutic Targeting Strategies of Cancer Stem Cells in Gastrointestinal Malignancies |
| Q28072845 | Transarterial Therapies for Hepatocellular Carcinoma |
| Q38008950 | Translational medicine in hepatocellular carcinoma |
| Q33889185 | Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent |
| Q39684895 | Upregulation of vasohibin-1 expression with angiogenesis and poor prognosis of hepatocellular carcinoma after curative surgery |
| Q37565250 | Vascular endothelial growth factor polymorphisms are associated with osteosarcoma susceptibility |
| Q35235798 | c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma |
| Q59800874 | miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling |
| Q37410466 | miR-589-5p inhibits MAP3K8 and suppresses CD90(+) cancer stem cells in hepatocellular carcinoma |
| Q37330910 | miR-612 suppresses stem cell-like property of hepatocellular carcinoma cells by modulating Sp1/Nanog signaling |
| Q34673760 | miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal cancer |
Search more.